Call for Abstract

Asia Pacific Pharmaceutics & Drug Delivery Congress, will be organized around the theme “Recent advances and further challenges in Pharmaceutics”

Asia Pharmaceutics 2021 is comprised of 13 tracks and 0 sessions designed to offer comprehensive sessions that address current issues in Asia Pharmaceutics 2021.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

It’s the study of how a human body react differently against drugs and drug therapies, these changes are determined by the human genetic makeup or genes. This is the main reason why each and every human react differently towards a similar drug. This study helps drug manufacturers and providers to choose the right amount of dose for each individual patient, which is likely to work best on that patient’s body.


  • Track 1-1Molecular Biology
  • Track 1-2Geriatrics
  • Track 1-3Neurodegeneration
  • Track 1-4Bioinformatics

Medical treatments often react differently on each patients, in this case personalized medicine helps to predict the possible reaction a patient’s body might have after the administration of drug, and customized medical treatment is provided to the patient. This method is a breakthrough treatment process but it studies the patient's unique molecular reaction to a certain disease.


  • Track 2-1Precision medicine
  • Track 2-2Gene patenting
  • Track 2-3Genetic discrimination
  • Track 2-4Population screening

To study the cellular function of the nervous system and the neural mechanism of a person after taking a drug. There are two main categories of neuropharmacology i.e., behaviour and molecular. Behavioural Neuropharmacology deals with the study of how drugs affect the behavioural characteristic in patients, patient’s dependency on drug and addition towards the drug. Molecular Neuropharmacology involves the study of neurological reaction a person has towards a drug.


It includes the study of physical, biochemical and biological characteristics of drugs derived from natural origins.


Drug design is the process of discovering and designing new drugs, medication based on the knowledge of the targeted molecule. The drug acts as an activator/inhibitor on the biological molecule such as protein and hence in turn results in a therapeutic benefit to the affected person.


The introduction of Artificial Intelligence in the Pharmaceutical industry has made a difficult task easier such as lab test analysis, identifying inefficiencies, sensing the person’s medication need and monitoring, providing prescribed advice based on the patient’s medical records. The application of AI in the pharmaceutical industry is expanding day by day and helping to complete the complex and time taking task.

It’s the process of designing of drug that will target the small molecules such as peptides, RNAi, protein molecules, which results in the alteration of the phenotype of a cell or an organism in the desired manner.

Advanced drug delivery technologies enhance the absorption rate of drug, efficacy and the experience of patients towards the drug.

 The pharmaceutical industry is growing day by day with the introduction of new technologies but still, it is facing hurdles such as skilled professionals, increase in the development cost, protecting the new innovations.

Nanomedicine provides clinically useful devices and research tools to the pharmaceutical industry. It initiates an advanced commercial application in the pharmaceutical industry which includes drug delivery system, therapies, in vivo imaging and many more.


 It’s the process of designing a drug based on the targeted molecule and testing it for further modification, the testing of drugs is usually done by high-throughput screening (HTS).


 They are also named as a biological medical products. These drugs are extracted or semi synthesized from biological sources. These sources are mainly composed of sugars, proteins, nucleic acids, living cells or tissues.

The application of biomaterials in the drug delivery system has overcome the limitation we were facing in delivering drugs. It has increased the bioavailability at the site, reducing the side effect of drugs, designing drugs which are selective to specific organs/parts.